Attix Pharmaceuticals Recall: Uridine-5'Triphosphate Trisodium Salt active pharmaceutical
Attix Pharmaceuticals Recall: Uridine-5'Triphosphate Trisodium Salt active pharmaceutical is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Attix Pharmaceuticals; Product: Uridine-5'Triphosphate Trisodium Salt active pharmaceutical ingredient packaged in varying grams or kg in bags or dr
| Recalling firm | Attix Pharmaceuticals |
|---|---|
| Product | Uridine-5'Triphosphate Trisodium Salt active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada |
| Reason for recall | Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide to compounding pharmacies and research organizations. |
| Recall initiated | 20141114 |
| Recall number | D-946-2015 |
| Category | drug |
| Country | Canada |
$29/mo
Try RecallGuard →